Time to Uveitis Control with Methotrexate and Mycophenolate Mofetil.

Home » Publications » Time to Uveitis Control with Methotrexate and Mycophenolate Mofetil.
TitleTime to Uveitis Control with Methotrexate and Mycophenolate Mofetil.
Publication TypeJournal Article
Year of Publication2022
AuthorsBui AD, Kong CL, Kelly NK, Rathinam SR, Gonzales JA, Thundikandy R, Kanakath A, Murugan B, Vedhanayaki R, Lim LL, Suhler EB, Al-Dhibi HA, Doan T, Acharya NR
Corporate AuthorsFirst-line Antimetabolites as Steroid-sparing Treatment(FAST) Research Group
JournalOphthalmology
Date Published2022 Jan 24
ISSN1549-4713
Abstract

This subanalysis from the First-line Antimetabolites as Steroid-sparing Treatment Trial found no significant difference in the time to achieve a corticosteroid-sparing dosage of prednisone for patients with noninfectious uveitis treated with methotrexate versus mycophenolate mofetil.
DOI10.1016/j.ophtha.2022.01.020
Alternate JournalOphthalmology
PubMed ID35085661